Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Gluconate Cloths for CLABSI Prevention in Outpatient HSCT
NCT03030989Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorhexidine in central line-associated bloodstream infection (CLABSI), sponsored by University of Chicago. Started Jan 2017; status: completed.
02
Drugs
chlorhexidine
03
Conditions
central line-associated bloodstream infection (CLABSI)
Beyond the preview
Go deeper on NCT03030989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030989.